New study suggesting suicidal ideation risk for Novo’s Ozempic adds to ongoing safety debate zbecker Tue, 08/20/2024 – 15:37 More: New study suggesting suicidal ideation risk for Novo's Ozempic adds to ongoing safety debate Source: fierce
read moreLawmakers urge FDA to investigate clinical trials run in tandem with China’s military fkansteiner Tue, 08/20/2024 – 14:11 More: Lawmakers urge FDA to investigate clinical trials run in tandem with China's military Source: fierce
read moreTeva faces fresh Copaxone kickbacks case from Medicare providers as it defends against DOJ claims zbecker Tue, 08/20/2024 – 10:58 More: Teva faces fresh Copaxone kickbacks case from Medicare providers as it defends against DOJ claims Source: fierce
read moreRoche regains reputation crown among rare disease patient groups, with Amgen close behind apark Tue, 08/20/2024 – 10:56 More: Roche regains reputation crown among rare disease patient groups, with Amgen close behind Source: fierce
read moreAfter Europe deal, Organon pays $22.5M to expand Emgality marketing pact with Lilly fkansteiner Tue, 08/20/2024 – 10:28 More: After Europe deal, Organon pays .5M to expand Emgality marketing pact with Lilly Source: fierce
read more
Osteoporosis currently affects 3.8 million people in the UK, particularly impacting older women after menopause More: Theramex’s Eladynos recommended by NICE for post-menopausal bone disease Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals